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Interleukin-3 Induces Hepatocyte-Speciﬁc Metabolic
Activity in Bone Marrow–Derived Liver Stem Cells
Daniel Inderbitzin, M.D., Itzhak Avital, M.D., Adrian Keogh, Ph.D., Guido Beldi, M.D.,
Mattia Quarta, M.D., Beat Gloor, M.D., Daniel Candinas, M.D.
Bone marrow–derived adult liver stem cells (BALSC) are a promising target for the development of
future cell-based therapies for a variety of liver disorders.However, the ability of stemcells to fully function,
as hepatocytes, is limited and differentiation is time dependent. Therefore, it will be conducive to ﬁnd a
growth factor that is able to enhance liver-speciﬁc metabolic activity in freshly isolated liver stem cells.
Recently, a subpopulation of BALSC was isolated and characterized (β2-microglobulin–negative/ Thy-
1–positive cells). We hypothesized that using interleukin-3 (IL-3), a hematopoietic differentiation growth
factor, we may be able to enhance liver-speciﬁc metabolic activity in freshly isolated BALSC. Rat
BALSC from normal and injured livers (bile duct ligated) were isolated and stimulated with IL-3 in
culture. Cells were co-cultured with or without hepatocytes, separated by a semipermeable membrane.
We measured the effect of IL-3 on BALSC to metabolize ammonia into urea (a liver-speciﬁc metabolic
activity). IL-3 increased the ability of BALSC, puriﬁed from normal animals, to metabolize ammonia
into urea by several folds. Interestingly, no such effect was found in cell cultures from bile duct–
ligated animals. Additionally, co-cultures of BALSC with hepatocytes induced higher rate of ammonia
metabolism, which was further enhanced by IL-3. Our study indicates that IL-3 may be used as an agent
to enhance differentiation of BALSC, both qualitatively and quantitatively. It is conceivable that stem
cells may undergo IL-3 priming before their clinical application in cell transplantation or bioartiﬁcial liver
systems. (J GASTROINTEST SURG 2005;9:69–74)  2005 The Society for Surgery of the Alimentary Tract
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cell can be isolated from the bone marrow of adult
animals and humans, the clinical community has been
enthralled by the potential promise of stem cell–based
therapies for the treatment of the failing liver.1–9
Recently, we puriﬁed a heterogeneous population
of progenitor cells that differentiated both in vivo
and in vitro into hepatocytes.7,8 We sorted bone
marrow cells by means of MHC surface proteins and
found that various subpopulations expressed several
stem cell markers.7 Consequently, using magnetic
beads, we developed a two-step immunoisolation pro-
cedure, further purifying cells expressing hepatocyte-
speciﬁc markers. These β2-microglobulin–negative/
Thy-1–positive cells or bone marrow–derived adult
liver stem cells (BALSC) were capable of multilineage 2005 The Society for Surgery of the Alimentary Tract
Published by Elsevier Inc.differentiation, metabolizing ammonia into urea,
and producing albumin and α-fetoprotein (AFP).7
Furthermore, BALSC were able to repopulate and
repair injured livers.8
However, one caveat is the need of these cells to
be co-cultured with injured hepatocytes, separated by
a semipermeable membrane, to maximally function,
possibly due to yet unknown growth factor secreted
by the hepatocytes in an attempt to recruit stem cells
from the bone marrow.7
Interleukin-3 (IL-3) has a unique ability to stimu-
late the growth and differentiation of hematopoietic
stem cells.10–13 However, its effect on BALSC is not
known.14–19 Therefore, this study was undertaken to
systematically evaluate the effect of IL-3 on BALSC.
We report here on the effects of IL-3 on liver
stem cells in culture, with and without co-culturePresented at the Forty-Fifth Annual Meeting of The Society for Surgery of the Alimentary Tract, New Orleans, Louisiana, May 15–19, 2004
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common bile duct–ligated animals). This study
demonstrates that IL-3 might be used to stimulate
more efﬁcient function in freshly isolated BALSC, to
render them competent to be used in cell transplanta-
tion therapies or bioartiﬁcial systems.
MATERIAL AND METHODS
All animal experiments were approved by the local
committee for animal welfare in accordance with
the European Convention on Animal Care. Male
Sprague-Dawley rats (220–250 g; RCC Ltd., Fu¨llin-
sdorf, Switzerland) were used in all experiments.
There were eight experimental groups. In the ﬁrst
four (A–D), we isolated BALSC from the bone
marrow of normal animals, and in the remaining four
(E–H), the BALSC were derived from the bone
marrow of rats after 7 days of bile duct ligation.
We further divided groups A–D and E–H into cul-
tures with (C, D, G, and H) and without (A, B, E,
and F) IL-3 and/or co-culture (A, C, E, and G) with
syngeneic hepatocytes (Table 1).
Culture Media
Small hepatocyte culture media were prepared as
described previously7,20 and supplemented with 5%
heat-inactivated fetal calf serum (FCS; Invitrogen,
Basel, Switzerland). The following growth factors
were added to the cultures: hepatocyte growth factor
(25 ng/ml; R&D Systems, Minneapolis, MN), epi-
dermal growth factor (10 ng/ml; Biosource, Camar-
illo, CA), and IL-3 (groups C, D, G, and H; IL-3,
10 ng/ml; R&D Systems).
Serum Harvest
Whole rat blood was spun for 10 minutes at 1000g,
and 1 ml of sterile ﬁltered serum (5%, v/v) was added
to 19 ml of culture media.Hepatocyte Isolation
Hepatocytes from normal animals were isolated
by a two-step portal collagenase perfusion of the liver
as described previously by Berry and Friend.21 In
7-day bile duct–ligated animals, a retrograde perfu-
sion was performed through the inferior vena cava.
For co-culture experiments, freshly isolated hepato-
cytes were seeded at a density of 150,000 cells/cm2
onto a collagen-coated 0.4-µm, 6.5-mm Transwell-
COL-Inlay (CorningCostar Corporation, Bodenheim,
Germany), and the hepatocyte culture transferred to
an incubator with 5% (v/v) ofCO2 atmosphere at 37C.
Harvesting of Bone Marrow Cells, Isolation
and Culture of b2-Microglobulin–Negative,
Thy-1–Positive Cells
We isolated BALSC from bone marrow as de-
scribed recently by Avital and Inderbitzin.7 Freshly
isolated β2-microglobulin–negative/Thy-1–positive
cells were then seeded at a density of 50,000 cells/cm2
onto Matrigel-coated (25 µg/cm2; Becton Dickinson,
Bedford, MA), 24-well cell culture plates (Corning
Costar Corporation, Bodenheim, Germany). In the
co-culture groups, the COL-Inlay with attached
hepatocytes was inserted after 30 minutes, allowing
the BALSC to achieve full attachment to theMatrigel
layer. Single cultures and co-cultures were main-
tained in 500 µl of media, changed every 3 days.
Immunohistochemistry
Freshly isolated BALSC (β2-microglobulin–nega-
tive/Thy-1–positive cells) were cyto-spun on glass
slides, and the Universal Elite ABC Kit (PK-7200;
Vector Lab Inc., Burlingame, CA) was used to stain
for IL-3 receptor-α according to the manufacturer’s
guidelines (sc-681; Santa Cruz Biotechnology, Santa
Cruz, CA).
Determination of Urea Synthesis
At 3, 6, 9, and 12 days of culture, the hepatocyte
inlay was removed from the co-culture groups andTable 1. Experimental groups
Normal rat Bile duct–ligated rat
Group Coculture with hepatocyes Interleukin-3 Group Coculture with hepatocyes Interleukin-3
A Yes No E Yes No
B No No F No No
C Yes Yes G Yes Yes
D No Yes H No Yes
β2-Microglobulin–negative, Thy-1–positive bone marrow cells from normal (A–D) and bile duct–ligated rats (E–H) were cultured alone (B,
D, F, and H) or in coculture with isogeneic hepatocytes (A, C, E, and G), with (C, D, G, and H) or without interleukin-3 (A, B, E, and F).
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of ammonia in Dulbecco’s modiﬁed Eagle’s medium
(Sigma A 4514, 2.5 mmol/L, pH 7.40; Sigma Chemi-
cal, St. Louis, MO) was added to the BALSC cell
cultures. After 5 hours, 400µl of media were removed,
and ammonia and urea contents were determined
using an enzymatic colorimetric test kit (Kit 542 946;
Roche Diagnostics, Rotkreuz, Switzerland).
Real-time Polymerase Chain Reaction
Total RNA Extraction and Reverse Transcrip-
tion. BALSC were harvested from culture using
500 µl of TRIzol after complete removal of the media
and immediately after determination of urea for-
mation (Invitrogen AG). Total RNA was extracted
using the Promega Reverse Transcription System
(Promega Corporation, Madison, WI).
Expression of Albumin mRNA and 18S rRNA
Content
The content of 18S rRNA in each individual
culture dish was quantiﬁed by TaqMan real-time
polymerase chain reaction (PCR) (AB Applied
Biosystems, Rotkreuz, Switzerland). Average thresh-
old cycle values (cycle of threshold values) from tripli-
cate real-time PCRs were obtained. Standardization
of the metabolic signal for total cell number was
achieved with the following formula: (Urea forma-
tion/h)/(35 – CT value of 18S rRNA).22
AlbuminmRNAexpression by BALSCwas quanti-
ﬁed by real-time PCR using the following primers
and probe: forward primer: 5′-TTG GTG CAG
GAA GTA ACA GAC TTT-3′; reverse primer: 5′-
GTG TGA ATG GAC TTG TCA CAG TTT T-
3′; and TaqMan probe: 5′-FAM-CAA AAT CAT
GTGTCGCTGATGAGA ATGCC-TAMRA-3′.
Albumin ∆CT values were related to 18S rRNA
content in the following manner (∆CT albumin 
CT albumin – CT 18S rRNA).
Interleukin-3 Determination in Serum
IL-3 was measured using a colorimetric ELISA kit
(900-K48; PeproTech EC Ltd., London, UK).
Statistical Analysis
Results are expressed as mean  SD. We com-
pared parallel cultures from the same animal using a
paired t test. Intergroup comparisons were made
using the Student t test for normally distributed data.
For correction of pairwise multiple comparisons, Stu-
dent-Newman-Keulsmethodwas applied (Jandel Sci-
entiﬁc 1.0; Jandel Scientiﬁc, San Rafael, CA). The
signiﬁcance level was set at P  0.05.RESULTS
Interleukin-3 Receptor-a Surface Expression
Immunohistochemistry staining for IL-3 receptor-
α on BALSC from normal (n  3) and bile duct–
ligated (n  3) animals revealed that BALSC highly
express IL-3 receptor-α: 95  5.0% in normal ani-
mals and 98 2.5% in bile duct–ligated animals
(P  0.70).
Isolation of BALSC (b2-Microglobulin–
Negative, Thy-1–Positive Cells) from Normal
and Bile Duct–ligated Rats
All rats survived 7 days of bile duct ligation. Body
weight remained stable, and no signs of biliary or
abdominal infection were observed. The subpopula-
tion of β2-microglobulin–negative cells was increased
(400%) in bile duct–ligated animals (9.1  6.8% of
all nucleated cells of the bone marrow in normal
[n  28] versus 37.1  6.1% in bile duct–ligated ani-
mals [n  12], P 0.0001). To obtain a pure fraction
of albumin-positive cells, a Thy-1–positive selec-
tion was performed.7 Interestingly, no signiﬁcant dif-
ference in the total cell number obtained after the
second immunoisolation step was detected between
cells isolated from normal and bile duct–ligated ani-
mals (2.7  2.0% of all nucleated bone marrow cells
in normal versus 3.4  1.0% in bile duct–ligated ani-
mals, P  0.25).
Real-time PCR for Albumin
Albumin mRNA expression was assessed systemat-
ically in all BALSC used for culture experiments.
∆CT values for albumin mRNA in β2-microglob-
ulin–negative/Thy-1–positive cells from normal
(19.9  2.4) and bile duct–ligated animals (21.4
4.1) were not different.
Real-time PCR Analysis of 18S rRNA Content
The determination of 18S rRNA content in every
single culture dish by real-time PCR showed stable
CT values on culture days 3, 6, 9, and 12 (Table 2).
Although the average standard deviation of the CT
18S rRNA content in the groups E, F, G, and H
(cells from bile duct–ligated animals) was higher than
that in groups A, B, C, and D (cells from normal
animals), the statistical analysis revealed no signiﬁcant
differences among the eight experimental groups
(Table 2).
Ureagenesis
Urea synthesis from ammonia was determined in
BALSC on days 3, 6, 9, and 12 after removal of the
hepatocyte inlay from the co-culture (Table 3).
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Average 18S rRNA
Experimental group content (CT values  SD)
A 24.5  1.2
B 25.0  0.8
C 26.6  1.4
D 25.8  1.3
E 26.0  4.0
F 21.3  2.6
G 21.4  3.9
H 21.4  2.0
Total 18S rRNA content of the bone marrow–derived adult liver stem
cells was determined at 3, 6, 9, and 12 days in culture and did not
differ signiﬁcantly over time under the various culture conditions
examined, indicating constant cell number in all eight experimental
groups.
Addition of IL-3 to the culture media increased
the capacity of β2-microglobulin–negative/Thy-1–
positive cells for urea formation in cell cultures from
normal (A versus C, B versus D; P  0.05) but not
from bile duct–ligated animals (E versus G, F versus
H; P NS) (Fig. 1).
As BALSC in single culture (B, D, F, and H) and
co-culture (A, C, E, and G) were strictly isolated from
the same animal and kept in parallel cultures, a paired
statistical analysis was performed (A versus B, C
versus D, E versus F, G versus H). All co-culture
groups showed superior urea formation (P  0.05).
When comparing urea formation capacity of
BALSC from normal and bile duct–ligated donor
animals under the same culture conditions (groups A
versus E, B versus F, C versus G, D versus H), no
Table 3. Metabolism of ammonia into urea in bone
marrow–derived adult liver stem cells (BALSC)
Urea synthesis
(average  SD) in BALSC cultures
Experimental
group 3 Days 6 Days 9 Days 12 Days
A 1.3  0.2 1.0  0.3 1.9  0.1 1.4  0.4
B 1.3  0.4 0.5  0.1 1.4  0.2 0.8  0.1
C 2.2  1.2 2.1  0.9 3.0  0.7 3.4  1.5
D 1.4  0.6 1.8  1.3 1.6  0.2 2.0  0.3
E 1.2  0.8 2.0  0.4 3.3  2.7 3.1  0.1
F 1.1  1.0 1.1  0.4 2.7  2.2 1.5  1.1
G 2.3  0.7 2.9  0.6 3.9  0.6 3.7  0.2
H 2.0  0.1 2.0  0.1 2.9  0.1 2.9  0.2
Urea synthesis was signiﬁcantly increased (P  0.05) in BALSC from
normal animals after addition of interleukin-3 (groups C and D) but
unaltered in BALSC from bile duct–ligated animals (groups G and
H). All coculture groups (groups A, C, E, and G) showed superior
ureagenesis compared with single BALSC cultures (P  0.05). No
signiﬁcant differences were detected when comparing cell cultures
from normal animals with parallel cultures from bile duct–ligated
rats (groups A versus E; B versus F; C versus G; D versus H).signiﬁcant differences were detected between the
groups.
Interleukin-3 Levels in Serum
IL-3 levels in serum were determined in normal
(n  3, day 0), sham-operated (n  3, day 7), and bile
duct–ligated animals (n 3, day 7). Values were
below the detection limit of the ELISA Kit used
(0 ng/ml).
DISCUSSION
The effect of IL-3 on proliferation and differentia-
tion in early hematopoietic progenitor populations
is well recognized.10–13 However, its effect on other
progenitor cell populations like liver stem cells is
not known. Using immunohistochemistry on freshly
isolated BALSC revealed IL-3 receptor-α surface ex-
pression on virtually all β2-microglobulin–negative/
Thy-1–positive cells isolated from rat bone marrow.
This directed us toward the hypothesis that IL-3 may
have a differentiation effect on BALSC. To test this
hypothesis, we added IL-3 to cell cultures from
normal animals (group D), which resulted in signiﬁ-
cantly stronger urea formation. This effect elicited
a certain degree of excitementbecause itmayprovide a
way to circumvent one of the most crucial problems
in stem cell use for cell therapies. There are two
cardinal problems for clinical application of stem
cells: to obtain sufﬁcient quantities ready for cell
transplantation and to render these cells functional as
soon as possible. Our study demonstrated that induc-
ing hepatocyte-speciﬁc metabolic activity in BALSC
within days of culture is feasible.
Previously, it has been established that to render
BALSC functional in vitro, a co-culture with injured
isogeneic hepatocytes separated by a semipermeable
membrane is mandatory.7 Therefore, we compared
the effect of IL-3 (groups C and D) on ureagenesis
in cultures and co-cultures of BALSC from normal
animals (groups A and B) to the potentially addi-
tional inductive effect of co-culturing injured hepato-
cytes from bile duct–ligated animals with BALSC
(groups E and G). Although ammonia metabolism
into urea was impressively increased after stimulation
with IL-3 in BALSC cultures from normal animals
(groups A versus C, B versus D; P  0.05), the meta-
bolic signal was unaltered in BALSC co-cultures with
hepatocytes from bile duct–ligated rats (groups A
versus E, C versus G; PNS). Furthermore, no IL-3
was found in the serum of normal, sham-operated,
or bile duct–ligated animals, which indicates that the
induction of metabolic activity is highly speciﬁc for
IL-3.
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and bile duct–ligated (■  co-culture,   single culture) male rats were cultured in the presence
( ) or absence (…) of interleukin-3 (IL-3). Urea synthesis from ammonia was determined on days 3,
6, 9, and 12 and standardized for cell number. Average urea formation is depicted and was strongest in
group G. By addition of IL-3 to co-cultures of BALSC with hepatocytes from normal animals (group
C), strong ureagenesis was inducible.To further ascertain this phenomenon and to con-
trol for different cell numbers in the various cultures;
we demonstrated that IL-3 did not promote cell
expansion as 18S rRNA content was stable in all eight
culture conditions examined. This indicates a broader
biological spectrum for the multilineage hematopoietic
growth factor IL-3 than previously recognized.10–13
In culture experiments without tissue (liver) inte-
gration, mRNA or protein expression alone is not
considered a reliable marker for the identiﬁcation of
organ-speciﬁc stem cells.6 We therefore determined
the urea formation capacity of β2-microglobulin–
negative/Thy-1–positive bone marrow cells under
the culture conditions examined. The appliedmethod
of ammonia determination before and after urease
addition to the sample allows internal control of total
ammonia content. No background urea or ammonia
was detected in the culture media sample alone. Stan-
dardization of urea formation was achieved by rela-
tion of the metabolic signal to individual 18S rRNAcontent of the respective culture dish. This sensitive
method allows quantitative assessment of urea forma-
tion in low-density cell cultures.
From a clinical point of view, the constant cell
number in culture and the sustained urea formation
of group D are most important. Human adult progeni-
tor cell populations are readily accessible from the
bone marrow, the peripheral blood after granulocyte
colony-stimulating factor activation, and the umbili-
cal cord blood. However, it is a difﬁcult task to de-
velop a hormonally deﬁned culture medium that
propagates unlimited liver progenitor cell division
and liver-speciﬁc differentiation on demand. Interest-
ing reports from various groups14–19 include differ-
ent progenitor cell isolation procedures from the
bonemarrow and a variety of culture conditions used.
Due to the different end points chosen (e.g., mRNA
or protein expression of liver-speciﬁc genes like albu-
min), a comparison of the results obtained is not
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cyte growth factor, acetic ﬁbroblast growth, leucocyte
migration inhibition factor) to the culture media
remains unclear at best. Therefore, the hepatocyte-
speciﬁc metabolic capacity such as the urea produc-
tion should be included in future in vitro studies of
hepatic progenitor cell populations to obtain compa-
rable results.
All co-cultures showed stronger ureagenesis than
their corresponding parallel single cultures, and it is
a formidable task to determine the factors responsible
for this phenomenon. The BALSC cell pool, the
serum added to the culture media, and the dynamic
interplay between hepatocytes and BALSC during
co-culture will have to be carefully elucidated in
the future.
Based on the urea formation data obtained from
co-cultures, we conclude that hepatocytes exert a
direct inductive effect on β2-microglobulin–neg-
ative/Thy-1–positive cells in culture. In a comparable
in vitro study, Okumoto et al.16 showed a similar in-
duction of albumin expression in co-cultures of a
subpopulation of adult rat bone marrow cells with
hepatocytes. As the bone marrow and liver cells in
the described co-culture system are separated by a
0.4-µm membrane, direct cell-to-cell interaction is
precluded and paracrine soluble factors must be re-
sponsible for the induction of hepatocyte-speciﬁc
function. Cell fusion between hepatocytes and pro-
genitor cells as described as a potentially important
in vivo mechanism is physically excluded in the two-
chamber co-culture experiments.23,24
CONCLUSIONS
Ethical and immunologic considerations indicate
that adult bone marrow–derived liver stem cells may
be superior to embryonic stem cells. The ability of
IL-3 to induce strong liver-speciﬁc metabolic activity
in bonemarrow–derived liver progenitorsmay render
these cells more suitable for use in future cell-
based therapies.
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